IMAP advises Covalon on its acquisition of AquaGuard

Press Release

01 October 2018

Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV.V; OTCQX: CVALF), an advanced medical technologies company, specialising in woundcare, today announced that it has closed the acquisition (the “Closing”) of AquaGuard, the Seattle, Washington-based division of medical technologies company Cenorin, LLC. AquaGuard’s specialized products provide patients with crucial moisture protection for wound, surgical, and vascular access sites throughout the body while showering.

Covalon were advised on the buyside by an IMAP team which was led by Morrison Park (IMAP Canada) that included Ian Bussey of Assay Corporate Finance in London. Ian heads up the global IMAP team on Medical Devices and supported Covalon with their global search, approach and valuation of Aquaguard.